PAREXEL introduced the Perceptive Cloud for the life sciences industry, as part of the company’s recent alliance with Microsoft.  

Perceptive Cloud enhances PAREXEL Informatics solutions into a cloud infrastructure built on Microsoft Azure. It combines PAREXEL’s technology solutions with Microsoft’s cloud services and investment in global compliance certifications and enterprise-grade security. The first group of integrated cloud services will include LIQUENT InSight Regulatory Information Management (RIM), Study Start-Up, DataLabs Electronic Data Capture (EDC), Managed Access Programs, and IMPACT Clinical Trial Management (CTMS).

Perceptive Cloud is designed to ensure sensitive information stays secure across global environments. It represents the first milestone of the alliance between PAREXEL and Microsoft aimed at leveraging the cloud to optimize performance and to offer new clinical development solutions with site- and patient-centric technologies.

“In drug development today, the time to treatment continues to grow longer. This is due, in large part, to the use of conventional, disparate systems that simply digitize manual processes,” said Paul Bidez, vice president of Regulatory and Clinical Solutions for PAREXEL. “Perceptive Cloud represents an opportunity to automate and streamline workflows and provide greater access to high quality data, simplifying the drug development journey with the objective of ultimately bringing new therapies to patients sooner.”

“Most life sciences solutions to date have been developed with the end result in mind, not the user experience, creating bottlenecks and inefficiencies across the drug development chain,” said Paul Slater, Worldwide Industry Strategist, Pharmaceuticals, Microsoft Health. “Both Microsoft and PAREXEL are committed to developing technologies that better engage patients, sites and sponsors to optimize clinical and operational effectiveness and digitally transform health. The Perceptive Cloud is only the first step in this effort.”